Roche has confirmed that five patients taking its hemophilia therapy Hemlibra (emicizumab) have died, but has stressed to Pink Sheet that in all the cases the treating physician or investigator’s assessment was that the cause of death was unrelated to the Swiss major's potential blockbuster.
News of the deaths emerged after announcements from two patient advocacy groups in the US – the National Hemophilia Foundation...




